Mandate

Vinge Advises Cyril Acquisitions in Offer for Cision

May 07, 2008

Cyril Acquisition AB, owned by Triton Fund II, has made official an offer to acquire all shares in Cision AB. Cyril Acquisition offer SEK 20 in cash for each share, and SEK 33,94 for each convertible profit share. Cision is listed on the OMX Nordic Exchange Stockholm AB, Mid Cap. Vinge has acted as the principal advisor in the transaction and handled the legal aspects connected to corporate law, finance, competition and due diligence.
 
Vinge's team included partner Johan Cederlund, Christina Kokko and Michael Ståhl, joined by associates Pontus Enquist and Petter Elmstedt concerning corporate issues, Sara Axelsson concerning financial issues, Björn Petersson in labour affairs, and Peter Forsberg and Hanna Eklinder regarding competition issues. Mi Gustafsson, Per Larsson and Tina Hård was engaged in the due diligence process.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026